Por favor, use este identificador para citar o enlazar este ítem: http://www.dspace.uce.edu.ec/handle/25000/14958
Título : Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients.
Autor : Baldeón Rojas, Lucy Yadira
Weigelt, Karin
De Wit, Harm
Ozcan, Behiye
van Oudenaren, Adri
Sempértegui, Fernando
Sijbrands, Eric
Grosse, Laura
Freire, Wilma
Drexhage, Hemmo
Leenen, Pieter
Palabras clave : OBESIDAD
DIABETES TIPO 2
INSULINA
MOLÉCULAS INFLAMATORIAS
CITOCINAS PROINFLAMATORIAS
Fecha de publicación : 2014
Editorial : Bethesda: NCBI
Citación : Baldeón, Lucy y otros (2014). Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients. PLoS ONE, 9 (12): 1-16
Resumen : Background: There is increasing evidence that chronic inflammation is an important determinant in insulin resistance and in the pathogenesis of type 2 diabetes (T2D). MicroRNAs constitute a newly discovered system of cell regulation and in particular two microRNAs (miR-146a and miR-155) have been described as regulators and biomarkers of inflammation. Aim: To determine a putative association between the levels of miR-146a and miR155 in serum of T2D patients, clinical parameters and serological indicators of inflammation. Methods: We performed quantitative Real Time PCR (qPCR) of microRNAs from serum (56 Ecuadorian T2D ambulatory patients and 40 non-diabetic controls). In addition, we evaluated T2D-related serum cytokines. chemokines and growth factors using a commercially available multi-analyte cytometric bead array system. We correlated outcomes to clinical parameters, including BMI, HbA1c and lipid state. Results: The Ecuadorian non-diabetic controls appeared as overweight (BMI.25: patients 85%, controls 82.5%) and as dyslipidemic (hypercholesterolemia: patients 60.7%, controls 67.5%) as the patients. - The serum levels of miR-146a were significantly reduced in T2D patients as compared to these non-diabetic, but obese/dyslipidemic control group (mean patients 0.61, mean controls set at 1; p50.042), those of miR-155 were normal. - The serum levels of both microRNAs correlated to each other (r50.478; p,0.001) and to leptin levels. The microRNAs did not correlate to BMI, glycemia and dyslipidemia. - From the tested cytokines, chemokines and growth factors, we found IL-8 and HGF significantly raised in T2D patients versus non-diabetic controls (p50.011 and 0.023 respectively). Conclusions: This study shows decreased serum anti-inflammatory miR-146a, increased pro-inflammatory IL-8 and increased HGF (a vascular/insular repair factor) as discriminating markers of failure of glucose control occurring on the background of obesity and dyslipidemia.
URI : http://www.dspace.uce.edu.ec/handle/25000/14958
Aparece en las colecciones: Artículos Indexados - IM

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients..PDFARTÍCULO A TEXTO COMPLETO328.37 kBAdobe PDFVisualizar/Abrir


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.